H. Yasui et al. / Journal of Fluorine Chemistry 132 (2011) 222–225
225
(f) D.S. Reddy, N. Shibata, T. Horikawa, S. Suzuki, S. Nakamura, T. Toru, Chem.
Asian. J. 4 (2009) 1411–1415.
[7] (a) D. Enders, M.R.M. Hu¨ ttl, Synlett (2005) 991–993;
(b) D.D. Steiner, N. Mase, C.F. Barbas, Angew. Chem., Int. Ed. 44 (2005) 3706–
3710;
[14] General procedure for the catalytic enantioselective fluorination of 6: Cinchona
alkaloid (10 mol%) and 1 (1.2 equiv) in MeCN (1.0 mL) were stirred under nitro-
gen atmosphere at room temperature for 30 min. The K2CO3 (6.0 equiv) was then
added to the solution, and the reaction mixture was stirred for 30 min at 0 8C. A
solution of 6 in MeCN (0.5 mL) was added to the catalyst solution. The reaction
was stirred at the temperature for 2 days with monitoring by TLC. The reaction
was then stopped by the addition of 1 N HCl. The reaction mixture was diluted
with AcOEt, washed with saturated aqueous sodium bicarbonate solution, brine,
dried over Na2SO4 and the solvent was evaporated under reduced pressure. The
residue was purified by column chromatography on silica-gel eluting with
Hexane/AcOEt to give the fluorinated compounds 7. The ees of the products
were determined by HPLC analysis on CHIRALCEL OJ-H column.
[15] Synthesis of 7a: Reaction of 6a (22.1 mg, 0.075 mmol), 1 (54.0 mg, 0.090 mmol),
QN-1-naphthoate (3.6 mg, 0.0075 mmol) and K2CO3 (62.2 mg, 0.45 mmol) in
MeCN at 0 8C and purification by silica gel column chromatography (hexane/
AcOEt = 80/20) gave 7a (13.5 mg, 75%, 70% ee).; 1H NMR (600 MHz, CDCl3) d 2.96
(dd, J = 14.3, 30.2 Hz, 1H), 3.15 (dd, J = 17.6, 23.1 Hz, 1H), 3.38 (dd, J = 13.0,
17.0 Hz, 1H), 3.41 (dd, J = 13.9, 14.2 Hz, 1H), 7.24–7.30 (m, 5H), 7.36 (d,
J = 7.6 Hz, 1H), 7.40 (t, J = 7.5 Hz, 1H), 7.61 (dt, J = 1.2, 7.5 Hz, 1H), 7.81 (d,
J = 7.7 Hz, 1H); 19F NMR (188 MHz, CDCl3) d À153.3 (dddd, J = 13.0, 13.9, 23.1,
30.2 Hz, 1F); 13C NMR (150.9 MHz, CDCl3) (200.8 (d, J = 18.2 Hz), 150.4 (d,
J = 3.9 Hz), 136.2, 134.6 (d, J = 4.1 Hz), 133.9, 130.3, 128.4, 128.2, 127.2, 126.6,
125.1, 97.5 (d, J = 188.6 Hz), 40.3 (d, J = 24.6 Hz), 37.2 (d, J = 24.6 Hz); IR (neat):
3066, 3031, 2924, 1726, 1606, 1496, 1468, 1306, 1216, 1092, 1032, 913, 734,
701 cmÀ1; EI MS: m/z 240 (M+); HPLC: (CHIRALCEL OB-H, Hexane/iPrOH = 90/10,
1.0 ml/min, 254 nm) tR (major-(R)-isomer) = 9.7 min, tR (minor-(S)-iso-
mer) = 12.6 min (70% ee). The absolute configuration of 7a has already been
determined. See, references [3b,4,12].
(c) M. Marigo, D. Fielenbach, A. Braunton, A. Kjoersgaard, K.A. Jørgensen, Angew.
Chem., Int. Ed. 44 (2005) 3703–3706;
(d) T. Beeson, D.W.C. MacMillan, J. Am. Chem. Soc. 127 (2005) 8826–8828;
(e) Y. Huang, A.M. Walji, C.H. Larsen, D.W.C. MacMillan, J. Am. Chem. Soc. 127
(2005) 15051–15053.
[8] (a) D.Y. Kim, E.J. Park, Org. Lett. 4 (2002) 545–547;
(b) J. Nie, H.-W. Zhu, H.-F. Cui, M.-Q. Hua, J.-A. Ma, Org. Lett. 9 (2007) 3053–3056;
(c) S. Suzuki, H. Furuno, Y. Yokoyama, J. Inanaga, Tetrahedron Asymmetr. 17
(2006) 504–507;
(d) K. Shibatomi, Y. Tsuzuki, S.-I. Nakata, Y. Sumikawa, S. Iwasa, Synlett (2007)
551–554;
(e) M. Frings, C. Bolm, Eur. J. Org. Chem. (2009) 4085–4090;
(f) K. Shibatomi, H. Yamamoto, Angew. Chem. Int. Ed. 47 (2008) 5796–5798;
(g) X. Wang, Q. Lan, S. Shirakawa, K. Maruoka, Chem. Commun. 46 (2010) 321–
323;
(h) D.H. Paull, M.T. Scerba, E. Alden-Danforth, L.R. Widger, T. Lectka, J. Am.
Chem. Soc. 130 (2008) 17260–17261.
[9] G.S. Lal, G.P. Pez, R.G. Syvret, Chem. Rev. 96 (1996) 1737–1756.
[10] E. Differding, H. Ofner, Synlett (1991) 187–189.
[11] (a) N. Mase, Y. Watanabe, Y. Ueno, T. Toru, J. Org. Chem. 62 (1997) 7794–7800;
(b) Y. Watanabe, N. Mase, M. Tateyama, T. Toru, Tetrahedron Asymmetr. 10
(1999) 737–745.
[12] Y. Takeuchi, T. Suzuki, A. Satoh, T. Shiragami, N. Shibata, J. Org. Chem. 64 (1999)
5708–5711.
[16] Synthesis of 7b: Reaction of 6b (21.9 mg, 0.10 mmol), 1 (72.2 mg, 0.120 mmol),
(DHQ)2PYR (8.8 mg, 0.010 mmol) and K2CO3 (83.2 mg, 0.600 mmol) in MeCN at
0 8C and purification by silica gel column chromatography (hexane/AcOEt = 90/
10) gave 7b (6.8 mg, 41%, 58% ee).; 1H NMR (200 MHz, CDCl3) d 1.63 (d,
J = 22.8 Hz, 3H), 3.29 (dd, J = 12.2, 17.4 Hz, 1H), 3.41 (dd, J = 22.8, 17.4 Hz, 1H),
7.38–7.45 (m, 2H), 7.65 (td, J = 7.5, 1.2 Hz, 1H), 7.8 (dd, J = 7.9, 0.6 Hz, 1H); 19F
NMR (188 MHz, CDCl3) d À151.5 (ddq, J = 22.8, 12.2, 22.8 Hz, 1F); EIMS: m/z 164
(M+); HPLC: (CHIRALCEL OB-H, hexane/iPrOH = 80/20, 1.0 ml/min, 254 nm) tR
(major-(R)-isomer) = 8.5 min, tR (minor-(S)-isomer) = 27.4 min (58% ee). The ab-
solute configuration of 7b has already been determined. See, references [3b,4,12].
[13] Synthesis of 1: To a stirred solution of 5 (701 mg, 1.21 mmol) in MeCN (25 mL) in
the presence of sodium fluoride (508 mg, 12.1 mmol) was introduced 10% F2 gas
in N2 at –40 8C for 10 min. Insoluble materials were removed by filtration, and
concentrated in vacuo. The crude residue was purified by silica gel column
chromatography (hexane/AcOEt = 98/2) and gave 1 (414 mg, 57%) as a colourless
crystalline solid. M.p. = 135–136 8C; 1H NMR (200 MHz, CDCl3) d 1.45 (s, 36H),
3.75 (s, 6H), 7.09 (s, 4H); 19F NMR (188 MHz, CDCl3) d À38.6 (s); IR (KBr): 2971,
1396, 1182 cmÀ1; EIMS m/z (rel intensity): 600 (M+, 5.0), 582 (14), 283 (28), 91
(47), 57 (100).